The pharmaceutical industry is one of China's six heavily polluting industries. Recently, the China Chemical Pharmaceutical Industry Association revealed that China's new "Drug Industry Pollutant Emission Standard (Draft)" has been completed, and this standard is likely to be formally introduced next year. For chemical and pharmaceutical companies, this undoubtedly means a new round of environmental tests.
It is understood that the original pollution control standards for the pharmaceutical industry only stipulated the limits for the index of pharmaceutical raw materials, and the rest was performed according to other sewage disposal units in the chemical industry. However, this can no longer meet the needs of the development of pharmaceutical companies and environmental management. The new effluent standards will formulate pollutant discharge standards for APIs, chemical drugs, and biopharmaceuticals, respectively, and increase the emission indicators for some drug products. In the draft of the “Standardâ€, the COD pre-discharge standard for chemical raw materials was changed from 1000 mg/L to 500 mg/L, while the emission standard was changed from 300 mg/L to 150 mg/L. The mg/L emission standard gives a transition period of 3 years. According to the State Environmental Protection Administration, the reason why strict standards are set is because many pharmaceutical companies have reached a very serious level of environmental pollution.
According to relevant sources, increasingly strict environmental protection standards will increase the cost of chemical and pharmaceutical companies.
On July 13, North China Pharmaceutical Co., Ltd. stated that at present, North China Pharmaceutical has spent 200 million yuan to meet environmental protection requirements. Shijiazhuang Pharmaceutical Group has invested 350 million yuan in environmental protection in order to rectify its subsidiaries. Haizheng Pharmaceutical Co., Ltd. invested 130 million yuan in environmental protection. Guangji Pharmaceutical Co., Ltd., which had been exposed by CCTV for excessive discharge of pollutants, announced that the sewage treatment facilities for the initial construction did not meet the requirements of the environmental protection department, and the investment in the sewage treatment facilities under construction would need to increase by 31 million yuan, that is, the total investment would reach 43 million. Yuan can make the company's treated sewage meet the new standards of the environmental protection department. At the same time, after the new sewage treatment facilities are put into operation, it is estimated that the sewage treatment costs will increase by about 20 million yuan annually.
These large companies had previously focused on the construction of environmental protection facilities and had the ability to absorb costs. Therefore, they only needed to gradually increase input to reach new standards. However, for those companies with weak environmental protection in the past and smaller scales, the new standards made them face life and death. The new standard requires that new enterprises must design and produce in accordance with the new standards, and that old companies complete rectification within a three-year transitional period and are mandatory standards. Due to the fact that there are environmental pollution problems in various chemical raw material companies in China, the implementation of this standard will on the one hand cause many SMEs and process equipment obsolete enterprises to stop production or even shut down due to environmental problems; on the other hand, it will increase The threshold of the chemical raw material medicine industry makes it difficult for new companies to enter.
According to industry insiders, the introduction of the new standard will not only bring challenges but also opportunities to the chemical and pharmaceutical industry. In fact, currently, 20% to 30% of China's chemical and pharmaceutical companies have been able to meet the requirements of the new standard, and other companies can fully meet the standards through their own efforts. For biopharmaceutical companies, the pollution caused by the production process is relatively small, so the impact will not be too great. According to relevant persons from the State Environmental Protection Administration, some small pharmaceutical companies are low-level duplicated constructions that are not standardized in themselves, do not meet the requirements for healthy development of the industry, and have a very bad influence on the environment. Therefore, the threshold for the establishment of new standards is also conducive to regulating the order of the industry. To promote survival of the fittest.
The China Chemical Pharmaceutical Industry Association said that this year's environmental protection spending by pharmaceutical companies will reach several billion yuan, which is not a small figure. However, at present, the problem of environmental pollution has affected the social image of the entire industry. In order to reverse this situation, strict environmental protection is very necessary. If the policies are implemented effectively and in place, the new standards will be conducive to the survival of the fittest and healthy development of the industry.
It is understood that the original pollution control standards for the pharmaceutical industry only stipulated the limits for the index of pharmaceutical raw materials, and the rest was performed according to other sewage disposal units in the chemical industry. However, this can no longer meet the needs of the development of pharmaceutical companies and environmental management. The new effluent standards will formulate pollutant discharge standards for APIs, chemical drugs, and biopharmaceuticals, respectively, and increase the emission indicators for some drug products. In the draft of the “Standardâ€, the COD pre-discharge standard for chemical raw materials was changed from 1000 mg/L to 500 mg/L, while the emission standard was changed from 300 mg/L to 150 mg/L. The mg/L emission standard gives a transition period of 3 years. According to the State Environmental Protection Administration, the reason why strict standards are set is because many pharmaceutical companies have reached a very serious level of environmental pollution.
According to relevant sources, increasingly strict environmental protection standards will increase the cost of chemical and pharmaceutical companies.
On July 13, North China Pharmaceutical Co., Ltd. stated that at present, North China Pharmaceutical has spent 200 million yuan to meet environmental protection requirements. Shijiazhuang Pharmaceutical Group has invested 350 million yuan in environmental protection in order to rectify its subsidiaries. Haizheng Pharmaceutical Co., Ltd. invested 130 million yuan in environmental protection. Guangji Pharmaceutical Co., Ltd., which had been exposed by CCTV for excessive discharge of pollutants, announced that the sewage treatment facilities for the initial construction did not meet the requirements of the environmental protection department, and the investment in the sewage treatment facilities under construction would need to increase by 31 million yuan, that is, the total investment would reach 43 million. Yuan can make the company's treated sewage meet the new standards of the environmental protection department. At the same time, after the new sewage treatment facilities are put into operation, it is estimated that the sewage treatment costs will increase by about 20 million yuan annually.
These large companies had previously focused on the construction of environmental protection facilities and had the ability to absorb costs. Therefore, they only needed to gradually increase input to reach new standards. However, for those companies with weak environmental protection in the past and smaller scales, the new standards made them face life and death. The new standard requires that new enterprises must design and produce in accordance with the new standards, and that old companies complete rectification within a three-year transitional period and are mandatory standards. Due to the fact that there are environmental pollution problems in various chemical raw material companies in China, the implementation of this standard will on the one hand cause many SMEs and process equipment obsolete enterprises to stop production or even shut down due to environmental problems; on the other hand, it will increase The threshold of the chemical raw material medicine industry makes it difficult for new companies to enter.
According to industry insiders, the introduction of the new standard will not only bring challenges but also opportunities to the chemical and pharmaceutical industry. In fact, currently, 20% to 30% of China's chemical and pharmaceutical companies have been able to meet the requirements of the new standard, and other companies can fully meet the standards through their own efforts. For biopharmaceutical companies, the pollution caused by the production process is relatively small, so the impact will not be too great. According to relevant persons from the State Environmental Protection Administration, some small pharmaceutical companies are low-level duplicated constructions that are not standardized in themselves, do not meet the requirements for healthy development of the industry, and have a very bad influence on the environment. Therefore, the threshold for the establishment of new standards is also conducive to regulating the order of the industry. To promote survival of the fittest.
The China Chemical Pharmaceutical Industry Association said that this year's environmental protection spending by pharmaceutical companies will reach several billion yuan, which is not a small figure. However, at present, the problem of environmental pollution has affected the social image of the entire industry. In order to reverse this situation, strict environmental protection is very necessary. If the policies are implemented effectively and in place, the new standards will be conducive to the survival of the fittest and healthy development of the industry.
AK-47 Scope Mounts provide a sturdy platform to securely attach scopes, enhancing accuracy and versatility for various shooting applications. These mounts are designed specifically for AK-47 rifles, ensuring optimal fit and performance. With easy installation and durable construction, AK-47 scope mounts offer precision and adaptability to improve your rifle.
Options include side mounts, top mounts, and Picatinny rails. Quality mounts withstand recoil while keeping your optic steady for repeatable precision. An AK-47 scope mount allows quick target acquisition and can make your rifle more accurate at various ranges. Find the ideal mount to enhance the capabilities of your AK-47.
Hunting,Riser Mounts ,Optics mount ,AK mount,tactical scope mounts
Guangzhou Miaozhun Jie Trade Co.,Ltd. , https://www.focuhunter.shop